Page last updated: 2024-11-06

prednisolone and Hyperimidodipeptiduria

prednisolone has been researched along with Hyperimidodipeptiduria in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sato, S1
Ohnishi, T1
Uejima, Y1
Furuichi, M1
Fujinaga, S1
Imai, K1
Nakamura, K1
Kawano, Y1
Suganuma, E1

Other Studies

1 other study available for prednisolone and Hyperimidodipeptiduria

ArticleYear
Induction therapy with rituximab for lupus nephritis due to prolidase deficiency.
    Rheumatology (Oxford, England), 2020, Oct-01, Volume: 59, Issue:10

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antibiotics, Antineoplastic; Drug The

2020